Evidence map›Paper›PMID 30674330›Full record

ArticleBiology direct2019

From tumors to species: a SCANDAL hypothesis.

A Y Panchin, V V Aleoshin, Y V Panchin

Abstract read
In one paragraph

Article in Biology direct, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Liquid biopsies and cancer omics.Cell death discovery · 2020
    Review
  8. Review
  9. Cancer predictive studies.Biology direct · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

A Y PanchinInstitute for Information Transmission Problems, Bolshoy Karetniy Pereulok 19/1, Moscow, Russian Federation, 127051. alexpanchin@yahoo.com.
V V AleoshinInstitute for Information Transmission Problems, Bolshoy Karetniy Pereulok 19/1, Moscow, Russian Federation, 127051.
Y V PanchinInstitute for Information Transmission Problems, Bolshoy Karetniy Pereulok 19/1, Moscow, Russian Federation, 127051.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ᅟ: Some tumor cells can evolve into transmissible parasites. Notable examples include the Tasmanian devil facial tumor disease, the canine transmissible venereal tumor and transmissible cancers of mollusks. We present a hypothesis that such transmissible tumors existed in the past and that some modern animal taxa are descendants of these tumors. We expect potential candidates for SCANDALs (speciated by cancer development animals) to be simplified relatives of more complex metazoans and have genomic alterations typical for cancer progression (such as deletions of universal apoptosis genes). We considered several taxa of simplified animals for our hypothesis: dicyemida, orthonectida, myxosporea and trichoplax. Based on genomic analysis we conclude that Myxosporea appear to be the most suitable candidates for a tumor ancestry. They are simplified parasitic cnidarians that universally lack major genes implicated in cancer progression including all genes with Caspase and BCL2 domains as well as any p53 and apoptotic protease activating factor - 1 (Apaf-1) homologs, suggesting the disruption of main apoptotic pathways in their early evolutionary history. Further comparative genomics and single-cell transcriptomic studies may be helpful to test our hypothesis of speciation via a cancerous stage. REVIEWERS: This article was reviewed by Eugene Koonin, Mikhail Gelfand and Gregory M Woods.

Indexed as

Biological EvolutionGenomeAnimalsEvolution, MolecularMyxozoaNeoplasmsCancerDevil facial tumor diseaseEvolutionMyxosporeaMyxozoaSimplificationSpeciationTransmissible tumor

Identifiers

PMID30674330
PMCPMC6343361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.